• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白 27 靶向的 PKCΔ 催化 V5 区七肽增强了对放化疗耐药的肿瘤的敏感性。

Heat shock protein 27-targeted heptapeptide of the PKCΔ catalytic V5 region sensitizes tumors with radio- and chemoresistance.

机构信息

Division of Radiation Effects, Korea Institute of Radiological and Medical Sciences, Seoul 136-706, Korea.

出版信息

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):221-30. doi: 10.1016/j.ijrobp.2010.11.069. Epub 2011 Feb 15.

DOI:10.1016/j.ijrobp.2010.11.069
PMID:21300481
Abstract

PURPOSE

Previous data suggest that the PKCδ catalytic V5 (PKCδ-V5) heptapeptide (HEPT) (FEQFLDI) binds HSP27 and blocks HSP27-mediated radio- or chemoresistance. Here we investigated further the in vivo function of the PKCδ-V5 HEPT.

METHODS AND MATERIALS

Labeling of HEPT with Cy5.5 or fluorescein isothiocyanate was performed to evaluate in vitro or in vivo distribution of HEPT. A clonogenic survival assay, flow cytometry, and Western blotting of cleaved caspase-3 were performed to determine in vitro sensitization effects of HEPT plus ionizing radiation (IR) versus IR alone or those of HEPT plus cisplatin(Cis) versus Cis alone. A nude mouse xenografting system was also applied to detect in vivo sensitizing effects of HEPT.

RESULTS

HEPT efficiently bound to HSP27 and showed sensitization after combined treatment with IR versus treatment with Cis alone in NCI-H1299 lung carcinoma cells, with higher HSP27 expression, which was similar to that of combined treatment with IR or with Cis alone in NCI-H460 lung carcinoma cells with lower HSP27 expression. In vivo image analysis using Cy5.5-labeled HEPT showed that HEPT was retained in HSP27-overexpressing cancer cells after xenografting to nude mice. Combined treatment of HEPT with IR versus that with Cis alone in xenografted mice showed that HEPT increased radio- or chemosensitization in NCI-H1299 cells compared to that in mice xenografted with NCI-H460 cells.

CONCLUSIONS

The novel PKCδ-V5 HEPT may help overcome HSP27-mediated radio- or chemoresistance.

摘要

目的

先前的数据表明,蛋白激酶 C δ 催化 V5(PKCδ-V5)七肽(HEPT)(FEQFLDI)与热休克蛋白 27(HSP27)结合并阻断 HSP27 介导的放射或化学耐药性。在这里,我们进一步研究了 PKCδ-V5 HEPT 的体内功能。

方法和材料

用 Cy5.5 或异硫氰酸荧光素标记 HEPT 以评估 HEPT 的体外或体内分布。通过克隆形成存活测定、流式细胞术和裂解的 caspase-3 的 Western blot 分析来确定 HEPT 加电离辐射(IR)与单独 IR 或 HEPT 加顺铂(Cis)与单独 Cis 相比的体外增敏作用。还应用裸鼠异种移植系统来检测 HEPT 的体内增敏作用。

结果

HEPT 有效地与 HSP27 结合,并在 NCI-H1299 肺癌细胞中与单独 Cis 处理相比,在 HSP27 表达较高的情况下,与 IR 联合治疗或单独 Cis 治疗相比表现出增敏作用,NCI-H460 肺癌细胞中 HSP27 表达较低。使用 Cy5.5 标记的 HEPT 的体内图像分析表明,HEPT 在裸鼠异种移植后保留在 HSP27 过表达的癌细胞中。与单独 Cis 处理相比,在裸鼠异种移植中 HEPT 与 IR 的联合处理表明,与 NCI-H460 细胞异种移植的小鼠相比,HEPT 增加了 NCI-H1299 细胞的放射或化学增敏作用。

结论

新型 PKCδ-V5 HEPT 可能有助于克服 HSP27 介导的放射或化学耐药性。

相似文献

1
Heat shock protein 27-targeted heptapeptide of the PKCΔ catalytic V5 region sensitizes tumors with radio- and chemoresistance.热休克蛋白 27 靶向的 PKCΔ 催化 V5 区七肽增强了对放化疗耐药的肿瘤的敏感性。
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):221-30. doi: 10.1016/j.ijrobp.2010.11.069. Epub 2011 Feb 15.
2
Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide.一种新型PKCδ-V5七肽对热休克蛋白27介导的DNA损伤剂抗性的抑制作用。
Cancer Res. 2007 Jul 1;67(13):6333-41. doi: 10.1158/0008-5472.CAN-06-4344.
3
Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance.姜烯酮通过改变 HSP27 的交联作用作为克服 HSP27 介导的放射抵抗的新策略。
Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1196-205. doi: 10.1016/j.ijrobp.2010.10.025.
4
Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.重楼苷 I 对人非小细胞肺癌细胞生长抑制作用及其在移植瘤模型中的作用
Acta Biochim Biophys Sin (Shanghai). 2010 Nov;42(11):827-33. doi: 10.1093/abbs/gmq091.
5
Tat-SmacN7 induces radiosensitization in cancer cells through the activation of caspases and induction of apoptosis.Tat-SmacN7 通过激活半胱天冬酶和诱导细胞凋亡来诱导癌细胞放射敏化。
Int J Oncol. 2013 Mar;42(3):985-92. doi: 10.3892/ijo.2013.1785. Epub 2013 Jan 22.
6
PKCδ promotes etoposide-induced cell death by phosphorylating Hsp27 in HeLa cells.PKCδ 通过磷酸化 HeLa 细胞中的 Hsp27 促进依托泊苷诱导的细胞死亡。
Biochem Biophys Res Commun. 2012 Oct 5;426(4):590-5. doi: 10.1016/j.bbrc.2012.08.132. Epub 2012 Sep 4.
7
Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27.肺癌干细胞的化学抗性取决于 Hsp27 的激活。
Cancer. 2011 Apr 1;117(7):1516-28. doi: 10.1002/cncr.25599. Epub 2010 Nov 8.
8
Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3.尼美舒利,一种选择性环氧化酶-2抑制剂,通过激活半胱天冬酶-8和半胱天冬酶-3,与电离辐射协同作用对抗A549人肺癌细胞。
Int J Oncol. 2009 May;34(5):1467-73.
9
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.MKP1/CL100调控非小细胞肺癌的肿瘤生长及对顺铂的敏感性。
Oncogene. 2006 Jun 1;25(23):3335-45. doi: 10.1038/sj.onc.1209364. Epub 2006 Feb 6.
10
Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells.胰岛素样生长因子-1 信号通路在顺铂耐药肺癌细胞中的作用。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e563-72. doi: 10.1016/j.ijrobp.2011.06.1999. Epub 2011 Dec 22.

引用本文的文献

1
Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing.缺氧诱导的癌细胞反应驱动缺氧肿瘤的放射抗性:靶向和放射增敏方法
Cancers (Basel). 2021 Mar 4;13(5):1102. doi: 10.3390/cancers13051102.
2
Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.利用小分子改变热休克蛋白27(HSP27)的二聚化来克服HSP27介导的耐药性。
Oncotarget. 2016 Aug 16;7(33):53178-53190. doi: 10.18632/oncotarget.10629.
3
Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.
蛋白激酶Cδ的多功能作用:人类疾病靶向治疗的机遇
Pharmacol Ther. 2016 Sep;165:1-13. doi: 10.1016/j.pharmthera.2016.05.001. Epub 2016 May 11.
4
Heat shock factor 1, an inhibitor of non-homologous end joining repair.热休克因子1,一种非同源末端连接修复的抑制剂。
Oncotarget. 2015 Oct 6;6(30):29712-24. doi: 10.18632/oncotarget.5073.
5
Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.热休克蛋白和热休克因子 1 在致癌作用和肿瘤发展中的作用:最新研究进展。
Arch Toxicol. 2013 Jan;87(1):19-48. doi: 10.1007/s00204-012-0918-z. Epub 2012 Aug 11.
6
Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells.鉴定热休克蛋白 27 为鼻咽癌细胞中的放射抵抗相关蛋白。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2117-25. doi: 10.1007/s00432-012-1293-0. Epub 2012 Jul 31.